FIELD: medicinal chemistry.
SUBSTANCE: invention relates to low-molecular conjugates of the antitumor monomethyl auristatin E, in which the active substance is connected to an N-acetylgalactosamine residue with a cleavable cathepsin B dipeptide linker valine-citrulline or a non-cleavable linker based on hex-5-ynic acid. A method of producing the conjugate and its use for the preparation of a pharmaceutical composition for the treatment of hepatocellular carcinoma are also proposed.
EFFECT: conjugates are characterized by greater efficiency in relation to the ASGPR-expressing cell line (HepG2), and also have cytotoxicity at the level of medicinal products of similar action used in clinical practice, and are stable under conditions that mimic physiological ones (pH 5.0 and 7.4), but are subject to hydrolysis under the action of a mixture of Pronase enzymes.
12 cl, 4 dwg, 1 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CYTOTOXIC PEPTIDES AND ANTIBODY-DRUG CONJUGATES THEREOF | 2012 |
|
RU2586885C2 |
| NEW DISPIRO-INDOLINONES, MDM2/p53 INTERACTION INHIBITORS, METHOD FOR PRODUCTION AND APPLICATION | 2015 |
|
RU2629750C2 |
| NMDA RECEPTOR MODULATORS AND THEIR APPLICATION | 2012 |
|
RU2621049C2 |
| TETRAHYDROFURO(3,2-b)PYRROL-3-ONES AS CATHEPSIN K INHIBITORS | 2007 |
|
RU2456290C2 |
| MONOMETHYL AURISTATIN E CONJUGATE FOR PREPARING A COMPOSITION FOR TREATING PROSTATE CANCER | 2019 |
|
RU2729192C1 |
| METHOD OF OBTAINING DISPIROINDOLINONES | 2018 |
|
RU2682678C1 |
| ANTIVIRAL COMPOUNDS | 2010 |
|
RU2541571C2 |
| PHARMACEUTICAL COMBINATION OF ATYPICAL ANTIPSYCHOTIC AND NMDA MODULATOR FOR TREATMENT OF SCHIZOPHRENIA, BIPOLAR DISORDER, COGNITIVE DISORDER, AND CLINICAL DEPRESSION | 2016 |
|
RU2802972C2 |
| ALKYL2-{[(2R,3S,5R)-5-(4-AMINO-2-OXO-2H-PYRIMIDINE-1-YL)- -HYDROXY- TETRAHYDRO-FURAN-2-YLMETHOXY]-PHENOXY-PHOSPHORYLAMINO}-PROPTONATES, NUCLEOSIDE INHIBITORS OF RNA-POLYMERASE HCV NS5B, METHODS FOR PRODUCING AND USING THEM | 2013 |
|
RU2534613C2 |
| PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
